All about vaccines
All about vaccinesLast update: 21/01/2021
Vaccines have arrived in the Principality
Vaccination is one of the ways of tackling the virus. In the absence of a cure, it is, together with the use of barrier measures, the only way to protect yourself. It helps to avoid serious disease from the infection, hospitalisations, admissions to intensive care and deaths.
As Dr Jean-Michel Cucchi, President of the "Ordre des Médecins de Monaco", explains, "for our elderly, the vaccinations are highly effective. They are therefore the most effective vaccines for the people who need them most".
People who are allergic to one of the components of the vaccine should not be vaccinated. In addition to the mRNA molecule, the vaccine contains the following components:
- (4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate) (ALC-0315)
- 2-[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide (ALC-0159)
- 1,2-Distearoyl-sn-glycero-3-phosphocholine (DSPC)
- Disodium phosphate dihydrate
- Potassium dihydrogen phosphate
The first vaccine which has received a marketing authorisation and is being distributed in Europe is the Comirnaty vaccine from Pfizer and BioNTech.
You can view the leaflet for this vaccine here: Comirnaty vaccine leaflet.
Over time, it is likely that other vaccines will obtain marketing authorisations, and that the Principality will be able to use these:
- Messenger RNA-based vaccines (e.g. Pfizer/BioNTech, Moderna and CureVac)
- Viral vector (adenovirus) vaccines (e.g. AstraZeneca and Janssen (Johnson & Johnson)
- Subunit vaccines (e.g. Sanofi)
- Inactivated vaccines
Thus, it is likely that the vaccination campaign will make use of vaccines from different laboratories.
No. You must volunteer and give your consent to be vaccinated.
Currently, only one vaccine is available: Comirnaty, developed by Pfizer/BioNTech. On 6 January, Europe authorised a second vaccine, the one from Moderna. However, these two vaccines are based on the same platform and are quite similar. Other vaccines are still being studied and are likely to become available over the next few weeks and months.
Your family doctor should be your first port of call, since they know your medical history better than anyone else. All general practitioners have received training on the scientific advances that the currently available vaccine relies on. The COVID-19 Call Centre can also provide you with information.
The whole population is susceptible to contracting COVID-19.
However, some people are more at risk of severe forms. There is justification for these people to be vaccinated against COVID-19 on the basis of one or more of the following co-morbidities, which could lead to a serious form of the disease, such as:
- Obesity (BMI >30)
- COPD and severe respiratory failure
- Complicated arterial hypertension
- Heart failure
- Diabetes (Type 1 and Type 2)
- Chronic kidney failure
- Cancers and malignant haematological diseases that are active and date from fewer than 3 years ago
- Solid organ or haematopoietic stem cell transplantation
- Trisomy 21
- Others to be specified
If you have one or more of these risk factors, you can download the prescription form below and consult your doctor in order to justify vaccination against COVID-19.
Then, with this medical prescription, you should contact the call centre on 92.05.55.00 to inform them of your priority for vaccination.
An appointment for the vaccination will be arranged as soon as possible.